SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention is centered on SELLASs pivotal REGAL AML trial nearing its 80th death event, which would trigger the final efficacy analysis for GPS; the milestone remains unconfirmed, with the community debating whether the delayed event reflects unusually long survival or trial-design concerns. Bullish traders point to the reported survival tail and positive comments from pharmaceutical professionals, while bearish traders question the studys statistical power and outlook.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Q2 earnings and forward guidance are driving attention, with traders split between viewing the results as a modest beat and focusing on weak residential demand and limited near-term growth. The debate is amplified by potential U.S. restrictions on foreign-made inverters and Enphases longer-term IQ Solid-State Transformer opportunity for AI data centers, while the stocks sharp volatility has intensified bullish dip-buying and bearish criticism.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

Uncertainty over AST SpaceMobiles satellite production and launch cadence is driving attention, with traders criticizing management after BlueBird 14 was reported complete while BlueBirds 15 and 16 remained in progress and no firm launch update followed. Bulls view manufacturing progress, carrier partnerships and eventual direct-to-device service as intact, while bears argue repeated delays and limited communication could postpone commercialization and leave the stock vulnerable to broader high-beta and rate-driven selling.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcoms upcoming quarterly earnings report is the dominant catalyst, with traders focused on whether AI/custom-chip demand and forward guidance can clear elevated expectations. Bulls anticipate strong results, while skeptics cite debt and financing concerns, potential Google-related share loss to Marvell, and prior post-earnings selloffs as risks.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Unusual strength and volatility in GameStop warrants, despite mostly flat-to-lower common-stock trading, is driving speculation about warrant extensions, bondholder short covering, or other forthcoming corporate news ahead of quarterly earnings. Bullish traders view the activity as a possible squeeze signal, while skeptics attribute it to illiquidity, manipulation, or a temporary options-related move and warn the warrants could expire worthless.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Escalating Iran and Strait of Hormuz tensions, along with volatile oil prices, are driving attention to Carnival as traders weigh higher fuel costs and travel disruption risks. The community is divided between bearish short-term views tied to geopolitical headlines and bullish investors citing resilient bookings, debt reduction, buybacks, dividends, and perceived undervaluation.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Speculation about an upcoming Intel foundry partnership, particularly involving Nvidia or SK Hynix, is driving attention alongside the broader Nvidia-led AI semiconductor rally and possible U.S. chip tariffs. Traders are divided between expecting stronger demand and a short squeeze, and questioning the lack of a confirmed deal and Intels foundry profitability.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas stronger-than-expected second-quarter results and raised full-year outlook, supported by resilient beverage volume and demand, have driven a sharp rally toward record highs. Traders are largely treating KO as a defensive rotation and dividend holding, though some argue the valuation and momentum look overheated and are fading or shorting the move.

Under Armour, Inc. engages in the development, marketing, and distribution of branded performance apparel, footwear, and accessories for men, women, and youth. It operates through the following geographical segments: North America, EMEA, Asia-Pacific, Latin America, and Other. The company was founded by Kevin A. Plank in 1996 and is headquartered in Baltimore, MD.

Under Armour Inc - Ordinary Shares - Class A

Under Armour Inc Class A

Fairfax Financials reported accumulation of a substantial Under Armour stake is driving speculation about a potential take-private transaction and fueling short-squeeze interest amid elevated short positioning. Traders remain divided, with bulls citing insider and institutional buying and turnaround prospects while skeptics point to weak demand, competition, and management concerns.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

Hawkish Federal Reserve commentary and rising rate-hike expectations are driving volatility in leveraged Nasdaq exposure, with traders highlighting Treasury-yield pressure, a technology selloff, and bearish technical signals. Ongoing U.S.-Iran tensions and higher oil prices are adding to concerns about inflation and further market downside, though some traders view the pullback as a buying opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Collegium Pharmaceutical (COLL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Collegium Pharmaceutical (COLL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of +14.29% and +1.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Tops Revenue Estimates

CRINETICS PHARM (CRNX) delivered earnings and revenue surprises of +7.32% and +69.28%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues 

COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech amid the ongoing sell-off and seek safer sectors.

New Strong Buy Stocks for July 6th

BBCP, KUBTY, ADM, COLL and W have been added to the Zacks Rank #1 (Strong Buy) List on July 6, 2026.

Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why

COLL gains momentum as strong Jornay PM growth and the Azstarys acquisition boosted 2026 guidance, strengthening its ADHD franchise and revenue outlook.

Bull of the Day: Neurocrine Biosciences (NBIX)

Neurocrine Biosciences (NBIX) has quietly become one of biotech's strongest earnings stories.

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

• Reported GAAP EPS of -$0.46 down -221.05% YoY
• Reported revenue of $199.88M up 6.32% YoY
• Collegium Pharmaceutical updated its full-year 2026 guidance, now expecting product revenues between $825 million and $855 million and adjusted EBITDA between $445 million and $470 million for the full year.

Collegium Pharmaceutical experienced a GAAP net loss, declining pain portfolio revenues due to Nucynta and Xtampza performance, and faces ongoing integration and regulatory risks related to its recent business acquisitions.

Collegium Pharmaceutical achieved significant growth in its ADHD portfolio, driven by record JORNAY PM adoption, and successfully completed the strategic acquisition of AZSTARYS to strengthen long-term revenue potential.

Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

Collegium Pharmaceutical Inc

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

COLL Collegium Pharmaceutical Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest COLL News